case_images: PMC11788304_01
case_images: Changes of CA125 throughout the process of the treatment.
case_images: fonc-15-1430474-g001.jpg
case_images: PMC11788304_01_fonc-15-1430474-g001.jpg
case_images: f1
case_images: October 21, 2020, it decreased to 18.8 U/mL, falling within the normal range ( Figure 1 ). On October 22, 2020, abdominal CT revealed the disappearance of metastatic lymph nodes in the abdominal cavity.
case_images: Abdominal CT scanning of the patient. (2020-08-07)The metastatic lymph nodes in the right posterior part of the hepatic artery were shown by CT before treatment. (2020-10-22 to 2023-08-25)After short-course hypofractionated radiation therapy combined with PD-1 inhibitors, CT revealed the disappearance of metastatic lymph nodes in the abdominal cavity. The therapeutic effect achieved a complete response.
case_images: fonc-15-1430474-g002.jpg
case_images: PMC11788304_01_fonc-15-1430474-g002.jpg
case_images: f2
case_images: The therapeutic effect achieved a complete response (CR) ( Figure 2 ), and maintenance treatment with camrelizumab continued until July 28th, 2022.